ResearcherChiba UniversityNo recent work listed
Fumio Nomura
Matched on ORCID iD 0000-0003-2361-7735; OpenAlex author ID A5043458895. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers
Papers 6
- Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s13402-021-00614-z↗
- Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2020.12388↗
- Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. Last author DOI 10.1111/cas.13181↗
- Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags. Last author DOI 10.1038/bjc.2016.295↗
- Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells. Co-author DOI 10.1016/j.jss.2012.05.065↗
- The application of a three-step proteome analysis for identification of new biomarkers of pancreatic cancer. Last author DOI 10.1155/2011/628787↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shigetsugu Takano · 6 shared papers, 2011–2021 · strength 0.39
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Kazuyuki Sogawa · 5 shared papers, 2011–2021 · strength 0.37
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Masayuki Ohtsuka · 4 shared papers, 2012–2021 · strength 0.31
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Masaru Miyazaki · 5 shared papers, 2011–2021 · strength 0.27
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Mamoru Satoh · 5 shared papers, 2011–2021 · strength 0.27
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Hideyuki Yoshitomi · 5 shared papers, 2011–2021 · strength 0.27
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Katsunori Furukawa · 3 shared papers, 2012–2021 · strength 0.26
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells. DOI 10.1016/j.jss.2012.05.065↗
- Yoji Miyahara · 2 shared papers, 2021 · strength 0.23
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Kosuke Sasaki · 2 shared papers, 2021 · strength 0.23
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Shingo Kagawa · 2 shared papers, 2012–2021 · strength 0.14
- Reiri Shimazaki · 1 shared paper, 2021 · strength 0.11
- Masayuki Otsuka · 1 shared paper, 2017 · strength 0.06
- Osamu Yokosuka · 1 shared paper, 2016 · strength 0.05
- Rintaro Mikata · 1 shared paper, 2016 · strength 0.05
- Mayinuer Abulaizi · 1 shared paper, 2011 · strength 0.02
- Takeshi Tomonaga · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.